A.T.Y. Ko

477 total citations
9 papers, 405 citations indexed

About

A.T.Y. Ko is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, A.T.Y. Ko has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in A.T.Y. Ko's work include Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers) and T-cell and B-cell Immunology (3 papers). A.T.Y. Ko is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers) and T-cell and B-cell Immunology (3 papers). A.T.Y. Ko collaborates with scholars based in United States, Canada and France. A.T.Y. Ko's co-authors include Linda A. Sherman, Javier Hernández, Isabelle Martins, Oliver Kepp, Laura Senovilla, Guillermo Mariño, Guido Kroemer, Michael Michaud, Éric Deutsch and Cyrus Chargari and has published in prestigious journals such as The Journal of Immunology, Cell Death and Differentiation and Cancer Letters.

In The Last Decade

A.T.Y. Ko

9 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.T.Y. Ko United States 7 182 129 117 100 57 9 405
Xiurong Shi United States 9 105 0.6× 195 1.5× 296 2.5× 59 0.6× 48 0.8× 9 535
Suxia Liu China 12 160 0.9× 66 0.5× 217 1.9× 86 0.9× 23 0.4× 15 380
Pamela A. Hankey United States 12 213 1.2× 35 0.3× 125 1.1× 71 0.7× 24 0.4× 16 421
Annemieke Walker United Kingdom 3 265 1.5× 45 0.3× 228 1.9× 83 0.8× 21 0.4× 5 513
Toshimitsu Kajiwara Japan 10 137 0.8× 84 0.7× 166 1.4× 59 0.6× 15 0.3× 14 367
Maike Schmitz Germany 5 50 0.3× 116 0.9× 249 2.1× 92 0.9× 34 0.6× 7 400
Jinglue Song China 10 55 0.3× 54 0.4× 243 2.1× 97 1.0× 23 0.4× 16 411
Agnieszka Chęcińska Netherlands 9 107 0.6× 108 0.8× 314 2.7× 182 1.8× 15 0.3× 10 477
Harriet A. Purvis United Kingdom 9 293 1.6× 28 0.2× 134 1.1× 69 0.7× 53 0.9× 11 436
S. Eisele Germany 8 81 0.4× 60 0.5× 110 0.9× 91 0.9× 34 0.6× 10 327

Countries citing papers authored by A.T.Y. Ko

Since Specialization
Citations

This map shows the geographic impact of A.T.Y. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.T.Y. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.T.Y. Ko more than expected).

Fields of papers citing papers by A.T.Y. Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.T.Y. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.T.Y. Ko. The network helps show where A.T.Y. Ko may publish in the future.

Co-authorship network of co-authors of A.T.Y. Ko

This figure shows the co-authorship network connecting the top 25 collaborators of A.T.Y. Ko. A scholar is included among the top collaborators of A.T.Y. Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.T.Y. Ko. A.T.Y. Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ko, A.T.Y., Nalan Gökgöz, Brendan C. Dickson, et al.. (2022). Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma. Cancers. 14(3). 548–548. 7 indexed citations
3.
Hung, Amos C., Chun‐Hao Tsai, Ming‐Feng Hou, et al.. (2015). The synthetic β-nitrostyrene derivative CYT-Rx20 induces breast cancer cell death and autophagy via ROS-mediated MEK/ERK pathway. Cancer Letters. 371(2). 251–261. 56 indexed citations
4.
Donald, L., A.T.Y. Ko, & Jeffrey Y. Kim. (2014). Bilingual flipcharts help improve oral health‐related knowledge and self‐efficacy of Korean‐American caregivers of preschoolers. Journal of Public Health Dentistry. 74(4). 261–265. 5 indexed citations
5.
Ko, A.T.Y., Isabelle Martins, Laura Senovilla, et al.. (2013). Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death and Differentiation. 21(1). 92–99. 161 indexed citations
6.
Hernández, Javier, A.T.Y. Ko, & Linda A. Sherman. (2001). CTLA-4 Blockade Enhances the CTL Responses to the p53 Self-Tumor Antigen. The Journal of Immunology. 166(6). 3908–3914. 41 indexed citations
7.
Morgan, David J., J Biggs, A.T.Y. Ko, et al.. (2000). Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas. The Journal of Immunology. 164(1). 191–200. 52 indexed citations
8.
Sherman, Linda A., David J. Morgan, Javier Hernández, et al.. (2000). Self-Tolerance and the Composition of T Cell Repertoire. Immunologic Research. 21(2-3). 305–314. 12 indexed citations
9.
Kreuwel, Huub T. C., David J. Morgan, Troy Krahl, et al.. (1999). Comparing the Relative Role of Perforin/Granzyme Versus Fas/Fas Ligand Cytotoxic Pathways in CD8+ T Cell-Mediated Insulin-Dependent Diabetes Mellitus. The Journal of Immunology. 163(8). 4335–4341. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026